CIK: 0001479355
Total reported value
$93.0M
Reporting period: 2016-12-31 · Number of holdings: 21
VHCP Management, LLC disclosed 21 holdings in its latest 13F filing for the period ending 2016-12-31, with total reported value of $93.0M and a quarterly turnover rate of 23.6%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "V"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add BCRX
+14.9% $2.9M
Trim HRTX
0.0% -$4.5M
Add F2927N109
0.0% -$1.4M
Add CHRS
0.0% $419.0K
Trim ADVMCHF
0.0% -$1.3M
Trim 338488109
0.0% -$1.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | DBV Technologies | Stock-Other | 33.47% | +1.52% | — | |
| 2 | HRTX | Heron Therapeutics INC | Stock-Other | 15.43% | -3.14% | — | |
| 3 | CHRS | Coherus Oncology INC | Stock-Other | 9.25% | +1.20% | — | |
| 4 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 7.86% | +3.50% | +14.92% | |
| 5 | ✓ | Flamel Technologies-sp Adr | Stock-Other | 5.59% | -0.51% | — | |
| 6 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 3.80% | +3.80% | NEW | |
| 7 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 3.44% | -1.02% | — | |
| 8 | ✓ | Lipocine INC New | Stock-Other | 3.36% | -0.37% | — | |
| 9 | ✓ | Colucid Pharmaceuticals Inc Com | Stock-Other | 2.67% | +0.11% | — | |
| 10 | ✓ | Axovant Sciences LTD | Stock-Other | 2.46% | -0.08% | — | |
| 11 | ✓ | Ocera Therapeutics INC | Stock-Other | 2.06% | -0.16% | +6.48% | |
| 12 | ASND | Ascendis Pharma A/S | Stock-Other | 1.96% | +0.18% | — | |
| 13 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 1.82% | +0.44% | — | |
| 14 | STMLEUR | Stemline Therapeutics INC | Stock-Other | 1.56% | +0.12% | — | |
| 15 | ✓ | Alcobra Ltd | Stock-Other | 1.49% | -0.11% | — | |
| 16 | ✓ | ARCA biopharma Inc | Stock-Other | 1.42% | +0.13% | — | |
| 17 | ✓ | Stock-Other | 1.20% | -0.13% | — | ||
| 18 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.76% | -0.23% | — | |
| 19 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 0.29% | +0.03% | — | |
| 20 | ✓ | Pronai Therapeutics INC | Stock-Other | 0.09% | -0.01% | — | |
| 21 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 0.03% | -0.01% | — |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2016-12-31 | 21 | $93.0M | 24 | |
| 2016-09-30 | 24 | $101.7M | 25 | |
| 2016-06-30 | 23 | $96.5M | 31 | |
| 2016-03-31 | 23 | $115.2M | 44 | |
| 2015-12-31 | 21 | $165.5M | 86 | |
| 2015-09-30 | 30 | $390.1M | 43 | |
| 2015-06-30 | 27 | $354.5M | 63 | |
| 2015-03-31 | 26 | $434.3M | 39 | |
| 2014-12-31 | 26 | $363.5M | 60 | |
| 2014-09-30 | 21 | $222.5M | 50 | |
| 2014-06-30 | 17 | $187.1M | 37 | |
| 2014-03-31 | 16 | $192.4M | 52 | |
| 2013-12-31 | 17 | $185.8M | 51 | |
| 2013-09-30 | 18 | $181.1M | 54 | |
| 2013-06-30 | 17 | $134.7M | 0 |
VHCP Management, LLC's most significant position changes for 2016-12-31: New buy: Ra Pharmaceuticals INC (RARXEUR); Sold out: Zafgen INC (ZFGNUSD); Sold out: Beone Medicines Ltd-adr (ONC); Sold out: Achillion Pharmaceuticals (ACHNEUR); Sold out: Regenxbio INC (RGNX).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BCRX | Biocryst Pharmaceuticals INC | +3.5% | +14.92% | Add |
| 2 | ✓ | DBV Technologies | +1.5% | — | Unchanged |
| 3 | CHRS | Coherus Oncology INC | +1.2% | — | Unchanged |
| 4 | EWTX | Edgewise Therapeutics, Inc. | +0.4% | — | Unchanged |
| 5 | ASND | Ascendis Pharma A/S | +0.2% | — | Unchanged |
| 6 | ✓ | ARCA biopharma Inc | +0.1% | — | Unchanged |
| 7 | STMLEUR | Stemline Therapeutics INC | +0.1% | — | Unchanged |
| 8 | ✓ | Colucid Pharmaceuticals Inc Com | +0.1% | — | Unchanged |
| 9 | BOLDEUR | Audentes Therapeutics INC | 0% | — | Unchanged |
| 10 | ✓ | Pronai Therapeutics INC | 0% | — | Unchanged |
| 11 | AGLEUSD | Aeglea Biotherapeutics INC | 0% | — | Unchanged |
| 12 | ✓ | Axovant Sciences LTD | -0.1% | — | Unchanged |
| 13 | ✓ | Alcobra Ltd | -0.1% | — | Unchanged |
| 14 | ✓ | -0.1% | — | Unchanged | |
| 15 | ✓ | Ocera Therapeutics INC | -0.2% | +6.48% | Add |
| 16 | CTMX | Cytomx Therapeutics INC | -0.2% | — | Unchanged |
| 17 | ✓ | Lipocine INC New | -0.4% | — | Unchanged |
| 18 | ✓ | Flamel Technologies-sp Adr | -0.5% | — | Unchanged |
| 19 | ADVMCHF | Adverum Biotechnologies INC | -1% | — | Unchanged |
| 20 | HRTX | Heron Therapeutics INC | -3.1% | — | Unchanged |
| 21 | RARXEUR | Ra Pharmaceuticals INC | — | NEW | New buy |
| 22 | ZFGNUSD | Zafgen INC | — | EXIT | Sold out |
| 23 | ONC | Beone Medicines Ltd-adr | — | EXIT | Sold out |
| 24 | ACHNEUR | Achillion Pharmaceuticals | — | EXIT | Sold out |
| 25 | RGNX | Regenxbio INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2016-12-31 | 2017-02-13 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-12 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-12 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-13 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-14 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-13 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-13 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-13 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-14 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-13 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-15 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002021188
Total reported value
$93.0M
25 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001899059
Total reported value
$93.0M
38 stks
2023-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001599955
Total reported value
$93.1M
6 stks
2021-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001178579
Total reported value
$783.0
1 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Heron Therapeutics INC
CIK 0001442757
Total reported value
$57.0M
40 stks
2014-06-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Heron Therapeutics INC
CIK 0001671207
Total reported value
$11.8M
6 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Coherus Oncology INC